Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9323 |
High Similarity |
NPD1240 |
Approved |
0.9286 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9286 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9191 |
High Similarity |
NPD1510 |
Phase 2 |
0.9185 |
High Similarity |
NPD1607 |
Approved |
0.9058 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9058 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9034 |
High Similarity |
NPD7411 |
Suspended |
0.8993 |
High Similarity |
NPD1549 |
Phase 2 |
0.898 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8836 |
High Similarity |
NPD4380 |
Phase 2 |
0.8784 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8714 |
High Similarity |
NPD2796 |
Approved |
0.8662 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8633 |
High Similarity |
NPD6651 |
Approved |
0.8609 |
High Similarity |
NPD7075 |
Discontinued |
0.8543 |
High Similarity |
NPD7768 |
Phase 2 |
0.8533 |
High Similarity |
NPD7819 |
Suspended |
0.8533 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8516 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8506 |
High Similarity |
NPD6232 |
Discontinued |
0.8467 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8467 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8462 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8451 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8442 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8425 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8425 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8411 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8333 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8311 |
Intermediate Similarity |
NPD1512 |
Approved |
0.828 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.828 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.828 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8252 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8247 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8214 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8212 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8176 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8121 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8121 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8095 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8085 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8069 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8027 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8014 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7972 |
Intermediate Similarity |
NPD943 |
Approved |
0.7949 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7929 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7927 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7911 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7905 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7901 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7895 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD920 |
Approved |
0.7877 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7867 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7853 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.784 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7832 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.78 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7792 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7791 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7791 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.777 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7763 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7744 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7733 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7708 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7703 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7703 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7703 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7703 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7703 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7703 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7698 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7698 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7697 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7677 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7664 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7651 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7643 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7635 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7606 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7606 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7605 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7586 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7586 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7547 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7546 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7536 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7533 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD919 |
Approved |
0.75 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7471 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7432 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD3225 |
Approved |
0.74 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7397 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7378 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7361 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7361 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7357 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7315 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7292 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7285 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7234 |
Intermediate Similarity |
NPD1651 |
Approved |
0.723 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7212 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD37 |
Approved |
0.72 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7174 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7167 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7151 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7133 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7121 |
Intermediate Similarity |
NPD940 |
Approved |
0.7121 |
Intermediate Similarity |
NPD846 |
Approved |
0.7114 |
Intermediate Similarity |
NPD411 |
Approved |
0.7103 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7103 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7086 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7081 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD6502 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7075 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7073 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7072 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7072 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7072 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7072 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7072
|
Intermediate Similarity |
NPD6777 |
Approved |